Immuneering Corp. advanced stock charts by Barron's. View IMRX historical stock data and compare to other stocks, and exchanges.

Generally speaking, protein powder as a whole is good for offsetting inadequate protein intake from food. Ingredients matter, ...

Frailty is a condition characterized by increased vulnerability and decline in physical function. It's a growing concern in ...

Up to 80% of patients with cancer experience muscle wasting, known as cachexia, a debilitating complication marked by extreme fatigue, weight loss and lack of appetite. “It is one of the major ...

A dysfunction in muscle blood vessels could be to blame for the weak muscles and weight loss that most cancer patients ...

Cachexia is a process that accompanies many chronic diseases, and consists of a combination of wasting of lean body mass, increased energy expenditure, and a paradoxical loss of appetite.

Moreover, GB18 has previously received the clearance from U.S. Food and Drug Administration (FDA) for IND application on May 21st. GB18 is an innovative biologic product developed for the treatment of ...

Kexing Biopharm Co. Ltd. has announced IND clearances this month by China’s National Medical Products Administration (NMPA) and the U.S. FDA for GB-18, a biologic product for the treatment of cancer ...

Finally, we described existing therapeutic approaches and discussed potential new strategies that arose by targeting the link between adipose tissue and cachexia, with a view to providing directions ...